Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy With Racotumomab in Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients
- Status
- COMPLETED
- Phase
- N/A
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
- Status
- COMPLETED
- Phase
- NA
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
- Status
- COMPLETED
- Phase
- PHASE2
IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.
- Status
- COMPLETED
- Phase
- PHASE1
Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2